Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 2

Results: 13

Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm<sup>2</sup>: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 208, doi. 10.1002/cpdd.1368

By:

DuBois, Janet;
Jones, Terry M.;
Lee, Mark S.;
Falqués, Meritxell;
Kiyasova, Vera;
Jiménez, Gemma;
Otero, Raquel;
Jansat, Josep‐M.;
Aubets, Jordi;
Forconi, Rion James

Publication type:

Article

Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 128, doi. 10.1002/cpdd.1361

By:

Khwarg, Juyoung;
Chung, Woo Kyung;
Lee, Soyoung;
Yang, Eunsol;
Ryu, Chaelim;
Lee, Dae Young;
Lee, Min Jung;
Jang, In‐Jin;
Yu, Kyung‐Sang;
Lee, SeungHwan

Publication type:

Article

The Effect of BI 730357 (Retinoic Acid‐Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open‐Label, Non‐randomized, 2‐Period Fixed‐Sequence Trial in Healthy Subjects

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 197, doi. 10.1002/cpdd.1344

By:

Choi, HeeJae;
Huang, Fenglei;
Flack, Mary

Publication type:

Article

Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 180, doi. 10.1002/cpdd.1341

By:

Kalluri, Hari V.;
Rosebraugh, Matthew R.;
Boehm, Nils;
Locke, Charles;
Ziemann, Adam;
Xiong, Hao

Publication type:

Article

Population Pharmacokinetics of Tenofovir Alafenamide Fumarate and Its Metabolite Tenofovir in Healthy Chinese Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 168, doi. 10.1002/cpdd.1340

By:

Ji, Xingfang;
Li, Yunfei;
Wang, Zhipeng;
Gao, Yuan;
Wang, Ling

Publication type:

Article

Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 134, doi. 10.1002/cpdd.1334

By:

Fang, Yuan;
He, Xia;
Peng, Ai;
Yang, Yi qi;
Xiang, Jin

Publication type:

Article

Effect of a High‐Fat Diet on the Pharmacokinetics and Safety of Rivaroxaban in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 146, doi. 10.1002/cpdd.1330

By:

Sun, Xue;
Song, Haojing;
Liu, Huan;
Qiu, Bo;
Ding, Congyang;
Hu, Yiting;
Bai, Wanjun;
Dong, Zhanjun

Publication type:

Article

Pharmacokinetic and Bioequivalence Study of Lisinopril/Hydrochlorothiazide Tablet Under Fasting and Postprandial Conditions in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 160, doi. 10.1002/cpdd.1329

By:

Yang, Zhuan;
Mi, Xiaolan;
Li, Qin;
Chen, Lu;
Zeng, Yan;
Du, Peng;
Liu, Lin;
Liu, Shijing;
Zeng, Chen;
Zhang, Qian;
Zhou, Yan;
Xiong, Yun;
Li, Na;
Ze, Qiuyuan;
Chen, Jiyu;
He, Yan

Publication type:

Article

Comparison of Pharmacokinetics and Bioavailability of Fixed‐Dose Combination Tablet and Monotherapy Combination of Allisartan Isoproxil and Indapamide Sustained‐Release in Healthy Chinese Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 190, doi. 10.1002/cpdd.1327

By:

Fan, Ni;
Gongmin, Zhou;
Wenming, Cheng;
Jiao, Yang;
Ruijie, Zhang;
Yan, Chen;
Xiangming, Tong;
Yi, Wu

Publication type:

Article

A Bioequivalence Trial of Dienogest in Healthy Chinese Participants Under Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 140, doi. 10.1002/cpdd.1324

By:

Zhao, Chunyan;
Wang, Yuxia;
Shao, Yanhua

Publication type:

Article

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY‐IL1 in Three Patients with Cryopyrin‐Associated Periodic Syndromes.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 152, doi. 10.1002/cpdd.1318

By:

Hissaria, Pravin;
Kansagra, Kevinkumar;
Patel, Hardik;
Momin, Taufik;
Ghoghari, Ashok;
Patel, Harilal;
Sharma, Bhavesh

Publication type:

Article

Pharmacokinetics and Food Effect Between a 100‐mg Sustained‐Release Tablet and a 50‐mg Immediate‐Release Tablet of Vildagliptin in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 122, doi. 10.1002/cpdd.1313

By:

Yoo, Hyounggyoon;
Shin, Wonsuk;
Lee, BackHwan;
Park, JinSoo;
Lee, Yilseob;
Kim, Anhye

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 117, doi. 10.1002/cpdd.1115
Publication type:: Article